The article examines the features of the course of acute respiratory diseases in children with bronchial hyperreactivity. It highlights the specific clinical manifestations, risk factors, and the influence of bronchial hyperreactivity on disease progression and treatment outcomes. The study emphasizes the importance of early diagnosis, personalized therapy, and careful monitoring to prevent complications and improve recovery in pediatric patients with hyperreactive airways. The findings provide practical recommendations for clinicians to optimize management strategies and reduce the severity and recurrence of acute respiratory episodes in this vulnerable population.

Acute respiratory diseases, children, bronchial hyperreactivity, clinical features, pediatric pulmonology.

Bush, A. Asthma and Bronchial Hyperreactivity in Children. Pediatric Respiratory Reviews, 2015;16(3):210–217.

Martinez, F. D., & Vercelli, D. Asthma and Bronchial Hyperresponsiveness: Mechanisms and Management in Children. New England Journal of Medicine, 2013;368:2545–2554.

Gern, J. E., & Busse, W. W. Viral Respiratory Infection and Bronchial Hyperreactivity in Children. Pediatric Clinics of North America, 2012;59(2):235–252.

Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. 2023. [Online]. Available: https://ginasthma.org

Zhang, L., et al. Clinical Features and Management of Acute Respiratory Infections in Children with Hyperreactive Airways. Journal of Pediatric Pulmonology, 2020;55(6):1450–1458.

Hartert, T. V., et al. Recurrent Wheezing and Bronchial Hyperresponsiveness in Early Childhood. American Journal of Respiratory and Critical Care Medicine, 2017;195:120–127.

National Heart, Lung, and Blood Institute (NHLBI). Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. 2020. [Online]. Available: https://www.nhlbi.nih.gov